FORM 8-K

Company

NRX Pharmaceuticals, Inc.

Filed

July 21, 2022

Period of Report

July 18, 2022

Accession Number

0000950142-22-002278

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →